LGALS3 and inflammatory bowel disease: Downregulation of galectin-3 was demonstrated in inflamed intestinal mucosa of patients with inflammatory bowel disease, but elevated serum levels are present in patients with ulcerative colitis and Crohn’s disease [92,93].